Leadership Moves

With the retirement of former Board of Governors members William C. Rupp, MD, and Ronald H. Wender, MD, FACA, The Doctors Company is pleased to announce the appointment of new Board of Governors members Owen Garrick, MD, MBA, and Akhil Saklecha, MD, MBA, FACEP.

Owen Garrick, MD, MBA, is a physician-executive with extensive experience advancing clinical research. He was most recently Dean of Clinical Trials at Mayo Clinic, overseeing an ambitious strategy to bring the promise of these trials to more patients. Previously, Dr. Garrick served in senior leadership at CVS Health, McKesson, Novartis, and Merck, with responsibilities spanning clinical development, regulatory science, ethics, and health system management. Earlier in his career, he also held roles at MetLife and Goldman Sachs. Dr. Garrick earned an AB (bachelor of arts) in psychology from Princeton University, an MD from Yale School of Medicine, and an MBA from the Wharton School at the University of Pennsylvania.

Akhil Saklecha, MD, MBA, FACEP, is an emergency physician with more than three decades of experience at the intersection of medicine and innovation. He serves as a Managing Director on WittKieffer’s Global Investor-Backed Markets team, partnering with boards, investors, and executive teams across healthcare and life sciences. Previously, Dr. Saklecha served as Chief Scientific Officer for Acute Care at Danaher, where he led science and technology strategy across its diagnostics businesses, and as Managing Director of Cleveland Clinic Ventures, supporting the commercialization of medical technologies emerging from the academic health system. Board certified in emergency medicine, he continues to practice clinically on a part-time basis at Cleveland Clinic. Dr. Saklecha earned his medical degree through the combined BS/MD program at Northeast Ohio Medical University, and he holds an MBA from the University of Tennessee Haslam College of Business.